首页> 外文期刊>生物医学研究杂志(英文版) >Serum IL-1β and IL-18 correlate with ESR and CRP in multidrug-resistant tuberculosis patients
【24h】

Serum IL-1β and IL-18 correlate with ESR and CRP in multidrug-resistant tuberculosis patients

机译:耐多药结核病患者血清IL-1β和IL-18与ESR和CRP相关

获取原文
获取原文并翻译 | 示例
           

摘要

Dear Editor:The emergence of multidrug-resistant tuberculosis(MDR-TB)is bringing new challenges.MDR-TB is caused by Mycobacterium tuberculosis(M.tuberculosis)that is resistant to isoniazid and rifampicin,with or without resistance to other anti-tuberculosis drugs.Approximately 450,000 people developed MDR-TB worldwide in 2012 and an estimated 170,000 people died from the disease^([1]).Bacterial burden is not strictly correlated with disease progression,and several hallmarks of severe tuberculosis suggest that insufficiently

著录项

  • 来源
    《生物医学研究杂志(英文版)》 |2015年第5期|426-428|共3页
  • 作者单位

    Department of Respiratory Medicine,The First Affiliated Hospital of Nanjing Medical University,Nanjing, Jiangsu 210029,China;

    Department of Respiratory Medicine,The First Affiliated Hospital of Nanjing Medical University,Nanjing, Jiangsu 210029,China;

    Department of Respiratory Medicine,The First Affiliated Hospital of Nanjing Medical University,Nanjing, Jiangsu 210029,China;

    Department of Respiratory Medicine,The First Affiliated Hospital of Nanjing Medical University,Nanjing, Jiangsu 210029,China;

    Department of Respiratory Medicine,The First Affiliated Hospital of Nanjing Medical University,Nanjing, Jiangsu 210029,China;

    Department of Respiratory Medicine,The First Affiliated Hospital of Nanjing Medical University,Nanjing, Jiangsu 210029,China;

  • 收录信息 中国科学引文数据库(CSCD);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 呼吸道传染病预防;
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号